Major Depressive Disorder Clinical Trial
Official title:
Empower: Transcranial Direct Current Stimulation in Major Depressive Disorder: a Double-blind, Placebo-controlled, Randomized, Superiority Trial
A two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home.
n/a
| NCT number | NCT05202119 |
| Study type | Interventional |
| Source | Flow Neuroscience AB |
| Contact | Cynthia Fu, Phd MD |
| Phone | 020 8223 4119 |
| [email protected] | |
| Status | Recruiting |
| Phase | N/A |
| Start date | May 1, 2022 |
| Completion date | December 31, 2022 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
| Recruiting |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
| Suspended |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
Early Phase 1 | |
| Recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
| Active, not recruiting |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
| Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
| Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
| Active, not recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
| Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
| Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
| Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
| Recruiting |
NCT04422652 -
Combination of Novel Therapies for CKD Comorbid Depression
|
Phase 2 | |
| Completed |
NCT04799405 -
Home-based tDCS in Major Depressive Disorder
|
N/A | |
| Recruiting |
NCT03708159 -
Maintenance of Response After rTMS for Depression Using tDCS
|
N/A | |
| Recruiting |
NCT03363919 -
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
|
N/A | |
| Recruiting |
NCT04727229 -
Stellate Ganglion Block for Major Depressive Disorder.
|
Phase 4 | |
| Enrolling by invitation |
NCT04634669 -
Open-Label Safety Study of AXS-05 in Subjects With TRD
|
Phase 2 | |
| Recruiting |
NCT03307070 -
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
|
N/A | |
| Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
| Not yet recruiting |
NCT05227612 -
Psilocybin-assisted CBT for Depression
|
Early Phase 1 |